Your browser doesn't support javascript.
loading
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study.
Reyes, Carlen; Pistillo, Andrea; Fernández-Bertolín, Sergio; Recalde, Martina; Roel, Elena; Puente, Diana; Sena, Anthony G; Blacketer, Clair; Lai, Lana; Alshammari, Thamir M; Ahmed, Waheed-Ui-Rahman; Alser, Osaid; Alghoul, Heba; Areia, Carlos; Dawoud, Dalia; Prats-Uribe, Albert; Valveny, Neus; de Maeztu, Gabriel; Sorlí Redó, Luisa; Martinez Roldan, Jordi; Lopez Montesinos, Inmaculada; Schilling, Lisa M; Golozar, Asieh; Reich, Christian; Posada, Jose D; Shah, Nigam; You, Seng Chan; Lynch, Kristine E; DuVall, Scott L; Matheny, Michael E; Nyberg, Fredrik; Ostropolets, Anna; Hripcsak, George; Rijnbeek, Peter R; Suchard, Marc A; Ryan, Patrick; Kostka, Kristin; Duarte-Salles, Talita.
Affiliation
  • Reyes C; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Pistillo A; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Fernández-Bertolín S; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Recalde M; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Roel E; Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Puente D; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Sena AG; Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Blacketer C; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Lai L; Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Alshammari TM; Janssen Research and Development Titusville, Titusville, New Jersey, USA.
  • Ahmed WU; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Alser O; Janssen Research and Development Titusville, Titusville, New Jersey, USA.
  • Alghoul H; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Areia C; School of Medical Sciences, The University of Manchester, Manchester, UK.
  • Dawoud D; College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.
  • Prats-Uribe A; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Center, Oxford, UK.
  • Valveny N; College of Medicine and Health, University of Exeter, St Luke's Campus, Exeter, UK.
  • de Maeztu G; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Sorlí Redó L; Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine.
  • Martinez Roldan J; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Lopez Montesinos I; National Institute for Health and Care Excellence (NICE), London, UK.
  • Schilling LM; Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Golozar A; Center for Statistics in Medicine, NDORMS, University of Oxford, Botnar Research Center, Nuffield Orthopaedic Center, Oxford, UK.
  • Reich C; Real-World Evidence, TFS, Barcelona, Spain.
  • Posada JD; IOMED, Barcelona, Spain.
  • Shah N; Universitat Autonoma de Barcelona, Barcelona, Spain.
  • You SC; Department of Infectious Diseases, Hospital del Mar, Institut Hospital del Mar d'Investigació Mèdica (IMIM), Barcelona, Spain.
  • Lynch KE; Universitat Pompeu Fabra, Barcelona, Spain.
  • DuVall SL; Director of Innovation and Digital Transformation, Hospital del Mar, Barcelona, Spain.
  • Matheny ME; Department of Infectious Diseases, Hospital del Mar, Institut Hospital del Mar d'Investigació Mèdica (IMIM), Barcelona, Spain.
  • Nyberg F; University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.
  • Ostropolets A; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Hripcsak G; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Rijnbeek PR; Real-World Solutions, IQVIA, Cambridge, Massachusetts, USA.
  • Suchard MA; Stanford University School of Medicine, Stanford, California, USA.
  • Ryan P; Stanford University School of Medicine, Stanford, California, USA.
  • Kostka K; Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea (the Republic of).
  • Duarte-Salles T; VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, Utah, USA.
BMJ Open ; 11(12): e057632, 2021 12 22.
Article in En | MEDLINE | ID: mdl-34937726
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Hypertension Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: BMJ Open Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Hypertension Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: BMJ Open Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom